phase 2_completion
saveAstraZeneca Plc — tozorakimab (Phase II Trial Completion)
community read0 votes
Therapy area: Respiratory. Indication: Chronic Obstructive Pulmonary Disease (COPD)
Therapy area: Respiratory. Indication: Chronic Obstructive Pulmonary Disease (COPD)